UPL Limited, Uniphos House, C.D. Marg, 11th Road, Madhu Park, Khar (West), Mumbai - 400052, India

w: www.upl-ltd.com
e: [email protected]
t: +91 22 6856 8000

May 11, 2026

BSE Limited
Mumbai
National Stock Exchange of India Ltd
Mumbai

SCRIP CODE: 512070
SYMBOL: UPL

Sub.: Audited Consolidated and Standalone Financial Results for the year ended March 31, 2026, and recommendation of dividend

Dear Sir/Madam,

Further to our letter dated May 4, 2026, and in accordance with the requirements of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), we wish to inform you that the Board of Directors ("Board") at their meeting held today i.e. Monday, May 11, 2026, considered and approved the audited consolidated and standalone financial results of the Company for the financial year ended March 31, 2026. The aforesaid financial results were reviewed by the Audit Committee before approval by the Board.

Pursuant to Regulation 30 and 33 of the SEBI Listing Regulations, we are enclosing herewith audited consolidated and standalone financial results for the financial year ended March 31, 2026, along with audit reports issued by BSR & Co. LLP, Chartered Accountants, Statutory Auditors of the Company. The statutory auditors have issued an unmodified audit report on the financial results.

Further, the Board has recommended dividend of 300% i.e. Rs. 6/- per equity share on equity shares of Rs. 2/- each, subject to approval of members at the ensuing Annual General Meeting ("AGM"). The dividend will be paid within 30 days of the AGM.

The Board Meeting commenced at 11:15 a.m. and concluded at 01:10 p.m.

We request you to take the above information on records.

Thanking you,

Yours faithfully,

For UPL Limited

Sandeep
Digtally signed by
Sandeep Mohan
Deshmukh
Date:2026.05.11
13:14:07 +05'30'

Sandeep Deshmukh
Company Secretary and
Compliance Officer
(ACS-10946)

Encl.: As above

Cc.: 1. London Stock Exchange
2. Singapore Stock Exchanges
3. NSE IX

Registered Office: 3-11, GIDC, Vapi, Valsad - 396 195, Gujarat, India. P +91 260 2432716 CIN: L24219GJ1985PLC025132

B S R & Co. LLP
Chartered Accountants
14th Floor, Central B Wing and North C Wing
Nesco IT Park 4, Nesco Center
Western Express Highway
Goregaon (East), Mumbai – 400 063, India
Telephone: +91 (22) 6257 1000
Fax: +91 (22) 6257 1010

Independent Auditors Report

To the Board of Directors of UPL Limited

Report on the audit of the Consolidated Annual Financial Results

Opinion

We have audited the accompanying consolidated annual financial results of UPL Limited (hereinafter referred to as the “Holding Company”) and its subsidiaries (Holding Company and its subsidiaries together referred to as “the Group”), its associates and its joint ventures for the year ended 31 March 2026, attached herewith, being submitted by the Holding Company pursuant to the requirement of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“Listing Regulations”).

In our opinion and to the best of our information and according to the explanations given to us and based on the consideration of reports of other auditors on separate audited financial statements/financial information of the subsidiaries, associates and joint ventures, the aforesaid consolidated annual financial results:

a. include the annual financial results of the entities mentioned in Annexure I to the aforesaid consolidated annual financial results;
b. are presented in accordance with the requirements of Regulation 33 of the Listing Regulations in this regard; and
c. give a true and fair view in conformity with the recognition and measurement principles laid down in the applicable Indian Accounting Standards, and other accounting principles generally accepted in India, of consolidated net profit and other comprehensive income and other financial information of the Group for the year ended 31 March 2026.

Basis for Opinion

We conducted our audit in accordance with the Standards on Auditing (“SAs”) specified under section 143(10) of the Companies Act, 2013 (“the Act”). Our responsibilities under those SAs are further described in the Auditor’s Responsibilities for the Audit of the Consolidated Annual Financial Results section of our report. We are independent of the Group, its associates and its joint ventures in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the financial statements under the provisions of the Act, and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence obtained by us, along with the consideration of reports of the other auditors referred to in sub paragraph no. (a) of the “Other Matters” paragraph below, is sufficient and appropriate to provide a basis for our opinion on the consolidated annual financial results.

Management’s and Board of Directors/Designated Partners’ Responsibilities for the Consolidated Annual Financial Results

These consolidated annual financial results have been prepared on the basis of the consolidated annual financial statements.

The Holding Company’s Management and the Board of Directors are responsible for the preparation and presentation of these consolidated annual financial results that give a true and fair view of the consolidated net profit/ loss and other comprehensive income and other financial information of the Group including its associates and joint ventures in accordance with the recognition and measurement principles laid down

B S R & Co. (a partnership firm with Registration No. BA61223) converted into B S R & Co. LLP (a Limited Liability Partnership with LLP Registration No. AAS-8181) with effect from October 14, 2013

Registered Office:
14th Floor, Central B Wing and North C Wing, Nesco IT Park 4, Nesco Center, Western Express Highway, Goregaon (East), Mumbai – 400 063

BSR & Co. LLP

Independent Auditor's Report (Continued)

UPL Limited

in Indian Accounting Standards prescribed under Section 133 of the Act read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The respective Management and Board of Directors of the companies/Designated Partners of limited liability partnerships (LLP) included in the Group and the respective Management and Board of Directors of its associates and joint ventures are responsible for maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of each company/ LLP and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and the design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring accuracy and completeness of the accounting records, relevant to the preparation and presentation of the consolidated annual financial results that give a true and fair view and are free from material misstatement, whether due to fraud or error, which have been used for the purpose of preparation of the consolidated annual financial results by the Management and the Board of Directors of the Holding Company, as aforesaid.

In preparing the consolidated annual financial results, the respective Management and the Board of Directors of the companies/Designated Partners of limited liability partnerships (LLP) included in the Group and the respective Management and Board of Directors of its associates and joint ventures are responsible for assessing the ability of each company/ LLP to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the respective Board of Directors/ designated partners either intends to liquidate the company/ LLP or to cease operations, or has no realistic alternative but to do so.

The respective Board of Directors of the companies/ Designated Partners of the LLP included in the Group and the respective Management and Board of Directors of its associates and joint ventures is responsible for overseeing the financial reporting process of each company/ LLP.

Auditor's Responsibilities for the Audit of the Consolidated Annual Financial Results

Our objectives are to obtain reasonable assurance about whether the consolidated annual financial results as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated annual financial results.

As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

Identify and assess the risks of material misstatement of the consolidated annual financial results, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under Section 143(3) (i) of the Act, we are also responsible for expressing our opinion through a separate report on the complete set of financial statements on whether the company has adequate internal financial controls with reference to financial statements in place and the operating effectiveness of such controls.
Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures in the consolidated annual financial results made by the Management and Board of Directors.
Conclude on the appropriateness of the Management's and Board of Directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the appropriateness of this assumption. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the consolidated annual financial

185 West 100
Central Bldg. 240
North C.W. 100
Bronx (P.O.)
Bronx Office
Western Express Highway
Savannah (East)
Mumbai - 400 053

B S R & Co. LLP

Independent Auditor's Report (Continued)

UPL Limited

results or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Group and its associates and joint ventures to cease to continue as a going concern.

Evaluate the overall presentation, structure and content of the consolidated annual financial results, including the disclosures, and whether the consolidated annual financial results represent the underlying transactions and events in a manner that achieves fair presentation.
Obtain sufficient appropriate audit evidence regarding the financial statements/financial information of the entities within the Group and its associates and joint ventures to express an opinion on the consolidated annual financial results. We are responsible for the direction, supervision and performance of the audit of financial statements/financial information of such entities included in the consolidated annual financial results of which we are the independent auditors. For the other entities included in the consolidated annual financial results, which have been audited by other auditors, such other auditors remain responsible for the direction, supervision and performance of the audits carried out by them. We remain solely responsible for our audit opinion. Our responsibilities in this regard are further described in sub paragraph (a) of the "Other Matters" paragraph in this audit report.

We communicate with those charged with governance of the Holding Company and such other entities included in the consolidated annual financial results of which we are the independent auditors regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

We also performed procedures in accordance with the circular No CIR/CFD/CMD1/44/2019 issued by the Securities and Exchange Board of India under Regulation 33(8) of the Listing Regulations, to the extent applicable.

Other Matters

a. The consolidated annual financial results include the audited financial results of 169 subsidiaries, whose financial statements/ financial information reflects total assets (before consolidation adjustments) of Rs. 283,443 crores as at 31 March 2026, total revenue (before consolidation adjustments) of Rs. 57,513 crores and total net profit after tax (before consolidation adjustments) of Rs. 4,580 crores and net cash outflows (before consolidation adjustments) of Rs. 2,557 crores for the year ended on that date, as considered in the consolidated annual financial results, which have been audited by their respective independent auditors. The consolidated annual financial results also include the Group's share of total net (loss) after tax of Rs. 115.21 crores for the year ended 31 March 2026, as considered in the consolidated annual financial results, in respect of 4 associates and 4 joint ventures, whose financial statements/ financial information have been audited by their respective independent auditors. The independent auditor's reports on financial statements/financial information of these entities have been furnished to us by the management.

Our opinion on the consolidated annual financial results, in so far as it relates to the amounts and disclosures included in respect of these entities, is based solely on the reports of such auditors and the procedures performed by us are as stated in paragraph above.

4 associates and 4 joint ventures are located outside India whose financial statements have been prepared in accordance with accounting principles generally accepted in their respective countries and which have been audited by other auditors under generally accepted auditing standards applicable in their respective countries. The Group's management has converted the financial statements of such associates and joint ventures located outside India from accounting principles generally accepted in their respective countries to accounting principles generally accepted in India. We have audited these conversion adjustments made by the Group's management. Our opinion in so far as it relates to the balances and affairs of such associates and joint ventures located outside India is based on the reports of other auditors and the conversion adjustments prepared by us.

B S R & Co. LLP

management of the Group and audited by us.

Our opinion on the consolidated annual financial results is not modified in respect of the above matter with respect to our reliance on the work done and the reports of the other auditors.

b. The consolidated annual financial results include the unaudited financial results of 16 subsidiaries, whose financial statements/ financial information reflects total assets (before consolidation adjustments) of Rs. 3,693 crores as at 31 March 2026, total revenue (before consolidation adjustments) of Rs. 264 crores, total net loss after tax (before consolidation adjustments) of Rs. 258 crores and net cash inflows (before consolidation adjustments) of Rs. 3 crores for the year ended on that date, as considered in the consolidated annual financial results. These unaudited financial statements/ financial information have been furnished to us by the Board of Directors. The consolidated annual financial results also include the Group's share of total net profit after tax of Rs. 21.08 crores for the year ended 31 March 2026, as considered in the consolidated annual financial results, in respect of 13 associates and 3 joint ventures. These unaudited financial statements/ financial information have been furnished to us by the Board of Directors.

Our opinion on the consolidated annual financial results, in so far as it relates to the amounts and disclosures included in respect of these subsidiaries, associates and joint ventures is based solely on such unaudited financial statements/ financial information. In our opinion and according to the information and explanations given to us by the Board of Directors, these financial statements/ financial information are not material to the Group.

Our opinion on the consolidated annual financial results is not modified in respect of the above matter with respect to the unaudited financial statements/financial information certified by the Board of Directors.

c. The consolidated annual financial results include the results for the quarter ended 31 March 2026 being the balancing figure between the audited figures in respect of the full financial year and the published unaudited year to date figures up to the third quarter of the current financial year which were subject to limited review by us.

For B S R & Co. LLP

Chartered Accountants

Firm's Registration No.:101248W/W-100022

Mumbai
11 May 2026

Membership No.: 105003
UDIN:26105003HUQASE5460

Page 4 of 13

Annexure I

List of entities included in consolidated annual financial results.

Sr. No.	Entity Name	Relationship
1	UPL Limited, India	Parent Company
2	Advanta Biotech General Trading Ltd	Subsidiary
3	Advanta Commercio de Sementes Ltda.	Subsidiary
4	Advanta Enterprises Limited	Subsidiary
5	Advanta Holdings (Thailand) Limited	Subsidiary
6	Advanta Holdings BV	Subsidiary
7	Advanta Holdings US Inc	Subsidiary
8	Advanta Mauritius Limited	Subsidiary
9	Advanta Netherlands Holdings BV	Subsidiary
10	Advanta Seeds (Wuhan) Company Ltd	Subsidiary
11	Advanta Seeds FZCO (FKA Advanta Seeds DMCC)	Subsidiary
12	Advanta Seeds Holdings UK Ltd	Subsidiary
13	Advanta Seeds Hungary Kft	Subsidiary
14	Advanta Seeds International	Subsidiary
15	Advanta Seeds Mexico, S.A. de C.V.	Subsidiary
16	Advanta Seeds Philippines Inc.	Subsidiary
17	Advanta Seeds Proprietary Ltd	Subsidiary
18	Advanta Seeds Pty Ltd	Subsidiary
19	Advanta Seeds Romania SRL	Subsidiary
20	Advanta Seeds Tanzania Limited	Subsidiary
21	Advanta Seeds Ukraine LLC	Subsidiary
22	Advanta Seeds Vietnam Company Limited	Subsidiary
23	Advanta Seeds Zambia LIMITED	Subsidiary
24	Advanta Semillas S.A.I.C.	Subsidiary
25	Advanta US, LLC	Subsidiary
26	Agrifocus LDA	Subsidiary
27	Agripraza Ltda	Subsidiary

16th Floor, Central B Wing and North C Plaza, Bldg 11, Pukk, Ncoco Centre, Western Express Highway, Guernsey Road, Mumbai - 400 063

UPL Limited

Sr. No.	Entity Name	Relationship
28	Agrovia LLC	Subsidiary
29	Anchorprops 39 Proprietary Ltd	Subsidiary
30	Anning Decco Biotech Co., Ltd.	Subsidiary
31	Arysta Agro Private Limited	Subsidiary (Dissolved w.e.f 8th August 2025)
32	Arysta Agroquimicos y Fertilizantes Uruguay S.A.	Subsidiary
33	Arysta Health and Nutrition Sciences Corporation	Subsidiary
34	Arysta LifeScience (Kenya) Ltd.	Subsidiary
35	Arysta LifeScience (Mauritius) Ltd	Subsidiary
36	Arysta LifeScience (Thailand) Co. Ltd.	Subsidiary
37	Arysta LifeScience Agriservice Private Limited	Subsidiary
38	Arysta LifeScience Asia Pte. Ltd.	Subsidiary
39	Arysta LifeScience Australia Pty Ltd.	Subsidiary
40	Arysta LifeScience Benelux SRL	Subsidiary
41	Arysta LifeScience Cameroun SA	Subsidiary
42	Arysta LifeScience CentroAmerica, S.A.	Subsidiary
43	Arysta LifeScience Corporation	Subsidiary
44	Arysta LifeScience Corporation Republica Dominicana, SRL	Subsidiary
45	Arysta LifeScience de Guatemala, S.A.	Subsidiary
46	Arysta LifeScience Great Britain Limited	Subsidiary
47	Arysta LifeScience Inc.	Subsidiary
48	Arysta LifeScience India Limited	Subsidiary
49	Arysta LifeScience Japan Holdings Goudou Kaisha	Subsidiary
50	Arysta LifeScience Management Company, LLC	Subsidiary
51	Arysta LifeScience Mexico, S.A.de C.V	Subsidiary (Merged with Grupo Bioquimico Mexicano, S.A. de C.V.)
52	Arysta LifeScience NA Holding LLC	Subsidiary
53	Arysta LifeScience Netherlands B.V.	Subsidiary
54	Arysta LifeScience North America, LLC	Subsidiary

B S R & Co. LLP
14th Floor,
Cuyang & Wing and
Sur B1C Wing,
Rescue 01 Park4,
Rescue Center,
Western Express Highway,
Gongyam (East),
Mumbai - 400 063

UPL Limited

Sr. No.	Entity Name	Relationship
55	Arysta LifeScience Ougrée Production SRL	Subsidiary
56	Arysta LifeScience Pakistan (Private) Limited	Subsidiary
57	Arysta LifeScience Philippines, Inc.	Subsidiary
58	Arysta LifeScience Registrations Great Britain Limited	Subsidiary
59	Arysta LifeScience S.A.S.	Subsidiary
60	Arysta LifeScience Services LLP	Subsidiary (Liquidated w.e.f 25th March 2026)
61	Arysta LifeScience U.K. JPY Limited	Subsidiary
62	Arysta LifeScience Vietnam	Subsidiary
63	Arysta-LifeScience Ecuador S.A.	Subsidiary
64	ASI SEEDS ENTERPRISES KENYA LIMITED	Subsidiary
65	Betel Reunion SA	Subsidiary
66	Biochemisch Dominicana, SRL	Subsidiary
67	Calli Ghana Co. Ltd.	Subsidiary
68	Callivoire SGFD S.A.	Subsidiary
69	Cerexagri	Subsidiary
70	Cerexagri B.V.	Subsidiary
71	Cerexagri, Inc. (PA),USA	Subsidiary
72	Chemagco LLC	Subsidiary
73	Citrashine (Pty) Ltd	Subsidiary
74	Decco Chile S.p.A	Subsidiary
75	Decco Gida Tarim ve Zirai Ürünler San. Tic A.S.	Subsidiary
76	Decco Holdings UK Limited	Subsidiary
77	Decco Iberica Postcosecha, S.A.U.	Subsidiary
78	Decco Israel Ltd	Subsidiary
79	Decco Italia S.R.L	Subsidiary
80	Decco PostHarvest Mexico, S.A. de C.V.	Subsidiary
81	Decco U.S. Post-Harvest, Inc	Subsidiary
82	Decco Worldwide Post-Harvest Holdings B.V.	Subsidiary

Sr. No.	Entity Name	Relationship
83	Decco Worldwide Post-Harvest Holdings Cooperatief U.A.	Subsidiary
84	Desarrollos Inmobiliarios Alianza de Coahuila, S.A. de C.V.	Subsidiary (Merged with Grupo Bioquimico Mexicano, S.A. de C.V.)
85	Grupo Bioquimico Mexicano Republica Dominicana, S.A.	Subsidiary
86	Grupo Bioquimico Mexicano, S.A. de C.V.	Subsidiary
87	Hannaford Nurture Farm Exchange Pty Ltd	Subsidiary (Liquidated w.e.f 21st December 2025)
88	Industrias Bioquim Centroamericana, S.A.	Subsidiary
89	Ingeagro S.A.	Subsidiary
90	Kudos Chemie Limited	Subsidiary
91	Laboratoires Goëmar SAS	Subsidiary
92	Laoting Yoloo Bio-Technology Corp., Ltd.	Subsidiary
93	Limited Liability Company "UPL"	Subsidiary
94	MacDermid Agricultural Solutions Australia Pty Ltd	Subsidiary
95	Mali Protection Des Culture (MPC) SA	Subsidiary
96	Myanmar Arysta LifeScience Co. Ltd.	Subsidiary
97	Naturagri Soluciones, S.L	Subsidiary
98	Natural Plant Protection Limited	Subsidiary
99	Nature Bliss Agro Limited	Subsidiary
100	Nurture Agtech Limited	Subsidiary
101	Pacific Seeds (Thai) Limited	Subsidiary
102	Pacific Seeds Holdings (Thailand) Limited	Subsidiary
103	Perrey Participações S.A	Subsidiary
104	Prolong Limited	Subsidiary (Liquidated w.e.f 5th November 2025)
105	PT Ace Bio Care	Subsidiary
106	PT Advanta Seeds Indonesia	Subsidiary
107	PT Arysta LifeScience Tirta	Subsidiary
108	PT Catur Agrodaya Mandiri	Subsidiary

Sr. No.	Entity Name	Relationship
109	PT EXCEL MEG INDO	Subsidiary
110	PT UPL Indonesia	Subsidiary
111	Riceco International Bangladesh Limited	Subsidiary
112	Riceco International, Inc.	Subsidiary
113	Sidewalk Trading Proprietary Ltd	Subsidiary
114	Superform Chemistries Limited	Subsidiary
115	Superform Chemistries Mauritius Ltd (FKA UPL Speciality Mauritius Limited)	Subsidiary
116	SWAL Corporation Limited	Subsidiary
117	Transterra Invest, S. L. U.	Subsidiary
118	Uniphos Industria e Comercio de Produtos Quimicos Ltda.	Subsidiary
119	Uniphos Malaysia SDN. BHD.	Subsidiary
120	United Phosphorus Global Services Limited	Subsidiary
121	United Phosphorus (India) Private Limited (FKA United Phosphorus (India) LLP)	Subsidiary
122	United Phosphorus Cayman Limited	Subsidiary
123	United Phosphorus Global LLP	Subsidiary
124	United Phosphorus Holdings Uk Limited	Subsidiary
125	UP Aviation Limited	Subsidiary
126	UPL (T) Ltd	Subsidiary
127	UPL Agri Mauritius Limited	Subsidiary
128	UPL Agricultural Product Trading FZE	Subsidiary
129	UPL Agricultural Solutions Holdings B.V.	Subsidiary
130	UPL Agricultural Solutions Italy SRL	Subsidiary (Liquidated w.e.f 25th March 2026)
131	UPL Agricultural Solutions SRL	Subsidiary
132	UPL Agro Limited	Subsidiary
133	UPL Agro, S.A. de C.V.	Subsidiary
134	UPL Agromed Tarim Ilaçlari ve Tohumculuk Sanayi ve Ticaret Anonim Sirketi	Subsidiary

B S R & Co. LLP
14th Floor
Central B Wing and
North C Wing,
Bristol IT Pty&4,
Riceco
Meadow Express Highway,
Goregon (East),
Mumbai - 400 060

Sr. No.	Entity Name	Relationship
135	UPL AgroSolutions Canada Inc.	Subsidiary
136	UPL AgroSolutions Mauritius Limited	Subsidiary
137	UPL Animal Health Holdings Limited	Subsidiary
138	UPL Arabia for Chemical Manufacturing	Subsidiary
139	UPL Argentina S.A.	Subsidiary
140	UPL Australia Pty Ltd	Subsidiary
141	UPL Benelux B.V.	Subsidiary
142	UPL Bolivia S.R.L	Subsidiary
143	UPL Bulgaria EOOD	Subsidiary
144	UPL Chile S.A.	Subsidiary
145	UPL Colombia S.A.S	Subsidiary
146	UPL Corporation Limited	Subsidiary
147	UPL Corporation Limited	Subsidiary
148	UPL Costa Rica, S.A.	Subsidiary
149	UPL Crop Protection Holdings Limited	Subsidiary
150	UPL Crop Protection Investments UK Limited	Subsidiary
151	UPL Czech s.r.o.	Subsidiary
152	UPL Delaware, Inc.,USA	Subsidiary
153	UPL Deutschland GmbH	Subsidiary
154	UPL do Brasil Industria e Comércio de Insumos Agropecuários S.A.	Subsidiary
155	UPL Egypt Ltd	Subsidiary
156	UPL Europe Ltd	Subsidiary
157	UPL Europe Supply Chain GmbH	Subsidiary
158	UPL France S.A.S	Subsidiary
159	UPL GCC Latam S.A.S.	Subsidiary
160	UPL Global Business Services Limited	Subsidiary
161	UPL GLOBAL FZCO (FKA UPL GLOBAL DMCC)	Subsidiary
162	UPL Global Limited	Subsidiary

B S R & Co. LLP
14th Floor,
Central © Wmg and
North C Wmg,
Illinois IT PtyNA,
Western Express Highway,
Corrigan 30405,
Murfreesboro, IL 600153

Sr. No.	Entity Name	Relationship
163	Upl Global Sustainable Agri Solutions Limited (FKA UPL Agri Science Ltd)	Subsidiary
164	UPL Health & Nutrition Science Holding Limited	Subsidiary
165	UPL Hellas SA	Subsidiary
166	UPL Holdings B.V.	Subsidiary
167	UPL Holdings Brazil B.V.	Subsidiary
168	UPL Holdings Cooperatief U.A.	Subsidiary
169	UPL Holdings SA Proprietary Ltd	Subsidiary
170	UPL Hungary KFT	Subsidiary
171	UPL IBERIA, S.A	Subsidiary
172	UPL Investments Southern Africa Proprietary Ltd	Subsidiary
173	UPL Investments UK Limited	Subsidiary
174	UPL Italia S.R.L.	Subsidiary
175	UPL Japan GK	Subsidiary
176	UPL Jiangsu Limited	Subsidiary
177	UPL LANKA (PRIVATE) LIMITED	Subsidiary
178	UPL LANKA BIO (PRIVATE) LIMITED	Subsidiary
179	UPL Limited	Subsidiary
180	UPL Limited Korea	Subsidiary
181	UPL Limited, Hong Kong	Subsidiary
182	UPL Management FZCO (FKA UPL Management DMCC)	Subsidiary
183	UPL Mauritius Limited	Subsidiary
184	UPL NA Inc.	Subsidiary
185	UPL New Zealand Limited	Subsidiary
186	UPL Nicaragua, S.A.	Subsidiary
187	UPL Paraguay S.A.	Subsidiary
188	UPL Peru S.A.C.	Subsidiary
189	UPL Philippines, Inc.	Subsidiary
190	UPL Polska Sp. z.o.o	Subsidiary

LLP

Sr. No.	Entity Name	Relationship
191	UPL Portugal, Unipessoal, LDA	Subsidiary
192	UPL Radicle II LP	Subsidiary
193	UPL Radicle LP	Subsidiary
194	UPL Services LLC	Subsidiary
195	UPL Shanghai Limited	Subsidiary
196	UPL Share Service Center, S.A. de C. V.	Subsidiary
197	UPL SL Argentina S.A.	Subsidiary
198	UPL Slovakia S.R.O	Subsidiary
199	UPL South Africa Proprietary Ltd	Subsidiary
200	UPL Sustainable Agri Solutions Limited	Subsidiary
201	UPL Switzerland AG	Subsidiary
202	UPL Togo SAU	Subsidiary
203	UPL Ukraine LLC	Subsidiary
204	UPL Vietnam Co., Ltd	Subsidiary
205	UPL Zambia Ltd	Subsidiary
206	UPL Ziraat Ve Kimya Sanayi Ve Ticaret Limited Sirketi	Subsidiary
207	Vetopharma SAS	Subsidiary
208	3SB Produtos Agricolas S.A.	Associates
209	Agri Fokus (Pty) Ltd.	Associates
210	Agronomic (Pty) Ltd.	Associates
211	Chemiesynth (Vapi) Limited	Associates
212	Dalian Advanced Chemical Co.Ltd.	Associates
213	Eswatini Agricultural Supplies Limited	Associates
214	Ho semillas Holding S.A.	Associates
215	Kerala Enviro Infrastructure Limited	Associates
216	Nexus AG (Pty) Ltd	Associates
217	Novon Protecta (Pty) Ltd	Associates
218	Novon Retail Company (Pty) Ltd.	Associates
219	Serra Bonita Sementes S.A.	Associates

Page 6 Go. LLP
14th Floor,
Front of Hong and
Bayside City,
Bayside, 11 Place,
Tizona Center,
Western Express Highway,
Elbergaon (East),
Mumbai - 400 003

Sr. No.	Entity Name	Relationship
220	Silvix Forestry (Pty) Ltd.	Associates
221	Sinova Inovacoes Agricolas S.A.	Associates
222	Société des Produits Industriels et Agricoles	Associates
223	Uniphos International China Ltd	Associates
224	Weather Risk Management Services Private Limited	Associates
225	Augene Chemical Private Limited	Joint Venture
226	Bioplanta Nutricao Vegetal,Industria e Comercio S.A.	Joint Venture
227	Grow Chemical Co., Ltd.	Joint Venture
228	Hodogaya UPL Co. Limited	Joint Venture
229	Longreach Plant Breeders Management Pty Limited	Joint Venture
230	Origeo Comercio de Produtos Agropecuarios S.A	Joint Venture
231	United Phosphorus (Bangladesh) Limited	Joint Venture

Page 13 of 13

| UPL Limited
CIN NO: L24219GJ1985PLC025132
Regd. Office: 3-11,G.I.D.C., Vapi, Dist: Valsad, Gujarat - 396 195
AUDITED CONSOLIDATED STATEMENT OF FINANCIAL RESULTS
(₹ in Crore) | | | | | | |
| --- | --- | --- | --- | --- | --- | --- |
| Sr.
No. | Particulars | Quarter ended | | | Year ended | |
| | | March 31,
2026 | December 31,
2025 | March 31,
2025 | March 31,
2026 | March 31,
2025 |
| | | (Unaudited)
(Refer note 9) | (Unaudited) | (Unaudited)
(Refer note 9) | (Audited) | (Audited) |
| I | Income | | | | | |
| | Revenue from operations | 18,335 | 12,269 | 15,573 | 51,839 | 46,637 |
| | Other Income | 178 | 92 | 107 | 663 | 486 |
| III | Total Income (I + II) | 18,513 | 12,361 | 15,680 | 52,502 | 47,123 |
| IV | Expenses | | | | | |
| | a) Cost of Raw materials and packing materials consumed | 6,469 | 6,362 | 5,796 | 23,928 | 18,289 |
| | b) Purchases of of stock-in-trade | 568 | 1,117 | 1,036 | 3,808 | 4,208 |
| | c) Changes in inventory of finished goods, work-in-progress, and stock-in-trade | 3,086 | (1,633) | 1,719 | (1,845) | 1,726 |
| | d) Employee benefits expense | 1,640 | 1,379 | 1,451 | 5,807 | 5,309 |
| | e) Finance costs (refer note 3) | 836 | 774 | 914 | 3,401 | 3,627 |
| | f) Depreciation and amortisation expense | 915 | 827 | 705 | 3,244 | 2,750 |
| | g) Impairment loss on financial assets (net) | 379 | 65 | 20 | 750 | 240 |
| | h) Exchange difference (net) on trade receivables, trade payables, etc. | 89 | 116 | 46 | 316 | 520 |
| | i) Other expenses | 2,546 | 2,546 | 2,314 | 9,803 | 8,745 |
| Total Expenses | 16,528 | 11,553 | 14,001 | 49,212 | 45,414 | |
| V | Profit before share of loss of associates and joint ventures, exceptional items and tax
(III - IV) | 1,985 | 808 | 1,679 | 3,290 | 1,709 |
| VI | Share of loss of associates and joint ventures, net of tax (refer note 4) | (77) | (81) | (27) | (194) | (472) |
| VII | Profit before exceptional items and tax (V + VI) | 1,908 | 727 | 1,652 | 3,096 | 1,237 |
| VIII | Exceptional Items loss/ (gain) (net) (refer note 5) | 16 | 56 | 275 | (61) | 408 |
| IX | Profit before tax (VII - VIII) | 1,892 | 671 | 1,377 | 3,157 | 829 |
| X | Tax expenses | 598 | 181 | 298 | 937 | 9 |
| | (a) Current Tax (refer note 6) | 488 | 187 | 272 | 1,243 | 295 |
| | (b) Deferred Tax | 110 | (6) | 26 | (306) | (286) |
| XI | Profit for the period (IX - X) | 1,294 | 490 | 1,079 | 2,220 | 820 |
| XII | Other Comprehensive Income | | | | | |
| | a) i) Items that will not be reclassified to profit or loss | (23) | 25 | 30 | 30 | 19 |
| | ii) Income tax relating to items that will not be reclassified to profit or loss | (4) | (1) | 1 | (3) | 2 |
| | b) i) Items that will be reclassified to profit or loss | 1,738 | 388 | 416 | 3,546 | 21 |
| | ii) Income tax relating to items that will be reclassified to profit or loss | - | - | - | - | - |
| | Total Other Comprehensive Income for the period, net of tax | 1,711 | 412 | 447 | 3,573 | 42 |
| | Total Comprehensive Income for the period | 3,005 | 902 | 1,526 | 5,793 | 862 |
| | Profit for the period | 1,294 | 490 | 1,079 | 2,220 | 820 |
| | Attributable to: | | | | | |
| | Owners of the Parent | 1,061 | 396 | 896 | 1,922 | 897 |
| XIII | Non-controlling interests | 233 | 94 | 183 | 298 | (77) |
| | Other Comprehensive Income for the period | 1,711 | 412 | 447 | 3,573 | 42 |
| | Attributable to: | | | | | |
| | Owners of the Parent | 1,398 | 320 | 433 | 2,754 | 63 |
| | Non-controlling interests | 313 | 92 | 14 | 819 | (21) |
| | Total Comprehensive Income for the period | 3,005 | 902 | 1,526 | 5,793 | 862 |
| | Attributable to: | | | | | |
| | Owners of the Parent | 2,459 | 716 | 1,329 | 4,676 | 960 |
| | Non-controlling interests | 546 | 186 | 197 | 1,117 | (98) |
| | Paid up Equity Share Capital (refer note 2) | 169 | 169 | 159 | 169 | 159 |
| (Face value of the share ₹ 2/- each) | | | | | | |
| XIV | Other Equity | | | | 34,527 | 29,054 |
| XVI | Earnings per equity share (not annualised) (refer note 2) | | | | | |
| | (Face value of the share ₹ 2/- each) | | | | | |
| | Basic (*) | 12.57 | 4.69 | 11.20 | 22.32 | 9.66 |

14th Floor, Central B Wing and North C Wing, Nersun D Padvi, Nersun Center, Western Express Highway, Goregaon (East), Mumbai - 400 1901

UPL Limited
CIN NO : L24219GJ1985PLC025132
Regd. Office: 3-11,G.I.D.C., Vapi, Dist: Valsad, Gujarat - 396 195
AUDITED CONSOLIDATED STATEMENT OF FINANCIAL RESULTS
FOR THE QUARTER AND YEAR ENDED MARCH 31, 2026

Notes:

The above audited consolidated statement of financial results of UPL Limited ("the Company"), its subsidiaries (together referred to as "the Group"), and its associates and joint ventures were reviewed by the Audit Committee and thereafter approved at the meeting of the Board of Directors on May 11, 2026. The statutory auditors have expressed an unmodified opinion. The audit report has been filed with the stock exchanges and is available on the Company's website. These audited consolidated statement of financial results have been prepared in accordance with the Indian Accounting Standards (Ind AS) notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time.
During the previous year ended March 31, 2025, the Company had issued 9,38,25,955 equity shares of face value of ₹ 2 each (the "Rights Equity Shares") at a price of ₹ 360 per rights equity share (including premium of ₹ 358 per rights equity share), in the ratio of 1 rights equity share for every 8 existing fully-paid equity shares held by the eligible equity shareholders as approved by the Board of Directors. An amount of ₹ 180 per equity share was received on application and first call comprising of ₹ 1 as share capital and ₹ 179 as premium. The Company had raised ₹ 1,668 Crores on application and first call during the previous year ended March 31, 2025. The total expense on Rights Issue aggregating to ₹ 35 Crores was adjusted against securities premium.

Further as of March 31, 2025, ₹ 16 Crores pending utilisation was kept in separate bank accounts which primarily related to the issue expenses paid by the Company from its own account and amount placed in Fixed Deposit. During the current year, this amount has been utilised towards general corporate expense purpose, and there is no outstanding in this bank account as of year ended March 31, 2026.

During the year ended March 31, 2026, the Company issued first call reminder notice against which ₹ 13 Crores was received. Further, during the year, the Company issued notice to the shareholders for payment of second (final) call money of ₹ 180 per equity share (comprising of ₹ 1 as share capital and ₹ 179 as premium) and final reminder cum forfeiture notice to the shareholders for payment of first call money, against which the Company has received ₹ 1,687 Crores. The Company raised ₹ 1,700 Crores on second (final) call, first call, and final reminder cum forfeiture notice. The Company forfeited and cancelled 264,278 partly paid-up equity shares of the face value of ₹ 2 each on which call money was unpaid. ₹ 0.27 Crores was transferred to Retained Earnings on account of forfeiture of shares during the year. Further, the Company has received ₹ 0.42 Crores towards interest on arrears of call money and is accounted as part of other income.

There has been no deviation in the use of proceeds of the Rights Issue, from the objects stated in the Offer document.

Pursuant to IND AS 33, basic and diluted earnings per share for the previous periods have been restated for the bonus elements in respect of the rights issue made.

Finance cost includes net exchange difference on account of (profit)/ loss arising on foreign currency loans, cost and mark to market losses on derivative contracts (including hedges) which is as follows: -

Particulars	Quarter Ended			Year Ended
	Mar-26	Dec-25	Mar-25	Mar-26	Mar-25
Amount in ₹ Crores	(48)	74	39	328	191

The share of profit /(loss) from equity accounted investee for the quarter and year ended March 31, 2026 is considered on the basis of audited financial information of the respective Associates/Joint Ventures for the year ended March 31, 2026, except for Sinova Inovacoes Agricola S.A., 3SB Produtos Agricolas S.A., Bioplanta Nutricao Vegetal Industria e Comercio S.A., Origeo Comércio De Produtos Agropecuários S.A., Ho Semillas Holdings S.A, Serra Bonita Sementas S.S. and Grow Chemical Co. Ltd where the audited financial information for the year ended December 31, 2025 have been considered.
Exceptional items include the following:

(₹ in Crores)

Particulars	Quarter Ended			Year Ended
	Mar-26	Dec-25	Mar-25	Mar-26	Mar-25
Restructuring cost (Including severance cost, impairment) ^	22	2	27	131	100
Impact of New Labour Codes #	-	59	-	59	-
Loss due to fire	-	-	9	-	24
Litigation Cost	-	-	6	-	20
Impairment of assets	-	-	-	-	31
VAT disallowance*	(6)	(5)	233	(251)	233
Total	16	56	275	(61)	408

^ During the year ended March 31, 2026, the Group initiated the closure of its Bassen manufacturing facility as part of restructuring plan to optimize operations and one-time costs of ₹ 98 Crores have been recognized under exceptional items, comprising employee severance and asset impairment. Balance cost amounting to ₹ 22 Crores and ₹ 33 Crores for the quarter and year ended March 31, 2026, respectively, pertains to various other restructuring activities and severance pay. These costs are non-recurring and have no continuing impact on the Group's operations.

On November 21, 2025, the Government of India notified four Labour Codes viz: the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020, and the Occupational Safety, Health and Working Conditions Code, 2020, collectively referred to as the 'New Labour Codes', consolidating 29 existing labour laws. On December 30, 2025, the Ministry of Labour & Employment published draft Central Rules and FAQs to enable assessment of the financial impact due to changes in regulations.

The Group has assessed and disclosed the financial implications of these changes as per the guidance provided by the Institute of Chartered Accountants of India. Considering the materiality and an enactment of the new legislation as an event of non-recurring nature, the Group has presented this incremental amount of gratuity as "Impact of New Labour Codes" under "Exceptional Item" in the Audited Consolidated Statement of Financial Results for the year ended March 31, 2026. The Group continues to monitor the finalization of Central / State Rules and clarifications from the Government of India pertaining to New Labour Codes and will evaluate impact if any on the measurement of the employee benefits liability in accordance with applicable accounting standards in the period in which they will be notified.

The Brazilian Supreme Court (STF) has ruled definitively that ICMS (state VAT) cannot be levied on inter-branch transfers of goods within the same legal entity for periods prior to January 1, 2024. This precedent applies directly to UPL Do Brasil – Industria e Comercio de Insumos Agropecuarios S.A. (UPL Limited) pending case before the São Paulo Appeal Court and eliminates a previously recognized tax

100% Limited
Carosil B Wrig and Norib C Wrig, Nosco IT PteNA, Nosco Carros, Western Express Highway, Garegon (East), Mumbai - 400 003

exposure. As a result, UPL Brasil has reversed the provision that had been recorded in the year ended March 31,2025, reflecting a one-time gain in the current year ended March 31, 2026.

Pursuant to the search operations conducted by the Income Tax authorities in the earlier years, block assessment u/s 153A of the Income Tax Act 1961 ('the Act') has been completed for the Assessment Years ('AY') 2014-15 to 2020-21 for corporate tax and transfer pricing for the earlier years.

During the year ended March 31, 2025, appellate authority adjudicated the matter in favour of the Company, consequent to this order, the Company reversed the tax provision amounting to ₹ 592 Crores, provided in the books, which was made in the earlier years given the uncertainty over the allowability of the eligible expenditure. Further, during the year ended March 31, 2026, the Company received tax refund along with interest u/s. 244A of the Income Tax Act, 1961. Interest on tax refund is accounted as part of other income.

In case of three overseas subsidiaries of UPL Limited, the Indian income tax authorities have invoked provisions of 'Place of Effective Management in India' for AY 2017-18 to AY 2020-21, and the provisions related to 'control and management wholly in India' for AY 2014-15 to AY 2016-17 and have started tax proceedings against these companies in India during the earlier years. Based on legal advice, the subsidiaries have challenged the proceedings before the appropriate authorities. The subsidiaries have been advised by legal counsel that they have strong grounds to succeed in the above matters.
The Board has recommended dividend of 300% on equity shares of ₹ 2/- each fully paid up (i.e. ₹ 6/- per equity share). This is subject to the approval of shareholders at the ensuing Annual General Meeting.
The figures of the quarter ended March 31, 2026, and March 31, 2025 are the balancing figures between the audited figures in respect of full financial year and the year-to-date unaudited figures upto the third quarter for the respective years. Also, the figures upto the end of third quarter had only been reviewed and not subjected to audit.
Audited Consolidated Balance Sheet, Audited Consolidated Statement of Cash Flows, and Audited Consolidated Segment Information prepared in accordance with Ind AS 108, Operating Segments are annexed herewith.
The Board of Directors based on recommendations of the Audit Committee and Committee of Independent Directors, approved a Composite Scheme of Arrangement ("the Scheme") on February 20, 2026, involving the amalgamation of UPL Sustainable Agri Solutions Limited ("UPL SAS" / "India Crop Protection business") into UPL Limited, demerger of the India Crop Protection business into UPL Global Sustainable Agri Solutions Limited ("UPL Global"), and amalgamation of UPL Crop Protection Holdings Limited ("UPLCL") into UPL Global. The appointed date for the merger of UPL SAS is April 1, 2026, the demerger and the UPLCL merger will be effective from the Scheme's Effective Date. The Scheme would be implemented under Sections 230 to 232, 234 and other applicable provisions of the Companies Act, 2013. The Scheme is subject to receipt of requisite approval / consents from the shareholders, regulators and NCLT approvals and is not yet effective. Accordingly, no effect has been given to the Scheme in these Audited Consolidated Statement of Financial Results for the year ended

UPL

CIN NO : L24219GJ1985PLC025132

Regd. Office: 3-11,G.I.D.C., Vapi, Dist: Valsad, Gujarat - 396 195

AUDITED CONSOLIDATED STATEMENT OF FINANCIAL RESULTS

FOR THE QUARTER AND YEAR ENDED MARCH 31, 2026

The Audited Consolidated Statement of Financial Results are rounded to the nearest Crores, except when otherwise indicated. Amounts represented by '0' (zero) construes value less than ₹ fifty lakhs.

For and on behalf of
UPL Limited

Raj Kumar Tiwari
DIN – 09772257
Whole-time Director

Place: Mumbai
Date: May 11, 2026

| UPL
UPL Limited
AUDITED CONSOLIDATED BALANCE SHEET
(₹ in Crore) | | |
| --- | --- | --- |
| Particulars | As at | |
| | March 31, 2026 | March 31, 2025 |
| | (Audited) | (Audited) |
| Assets | | |
| Non-current assets | | |
| Property, plant and equipment | 8,474 | 8,107 |
| Capital work-in-progress | 999 | 615 |
| Right-of-use assets | 1,440 | 1,324 |
| Goodwill | 22,954 | 20,675 |
| Other intangible assets | 9,285 | 8,978 |
| Intangible assets under development | 2,148 | 1,931 |
| Investments accounted for using the equity method | 1,262 | 1,394 |
| Financial assets | | |
| (i) Investments | 770 | 614 |
| (ii) Trade receivables | 469 | 7 |
| (iii) Loans | - | 21 |
| (iv) Other financial assets | 270 | 216 |
| Deferred tax assets (net) | 3,929 | 3,322 |
| Other tax assets (net) | 497 | 923 |
| Other non-current assets | 413 | 214 |
| Total non-current assets | 52,910 | 48,341 |
| Current assets | | |
| Inventories | 12,676 | 10,316 |
| Financial assets | | |
| (i) Investments | 634 | 320 |
| (ii) Trade receivables | 17,874 | 15,505 |
| (iii) Cash and cash equivalents | 5,975 | 9,478 |
| (iv) Bank balances other than (iii) above | 111 | 59 |
| (v) Loans | 203 | 25 |
| (vi) Other financial Assets | 1,027 | 746 |
| Current tax assets (net) | 415 | 341 |
| Other current assets | 3,247 | 2,827 |
| Total current assets | 42,162 | 39,617 |
| Assets classified as held for sale | 133 | 44 |
| Total Assets | 95,205 | 88,002 |
| Equity and liabilities | | |
| Equity | | |
| Equity Share capital | 169 | 159 |
| Other equity | 34,527 | 29,054 |
| Equity attributable to owners of the Parent | 34,696 | 29,213 |
| Non-controlling interests | 6,573 | 5,627 |
| Non-controlling interests- Perpetual Subordinated Capital Securities | - | 2,986 |
| Total Non-controlling interests | 6,573 | 8,613 |
| Total Equity | 41,269 | 37,826 |
| Liabilities | | |
| Non-current liabilities | | |
| Financial liabilities | | |
| (i) Borrowings | 15,535 | 18,263 |
| (ii) Lease liabilities | 1,021 | 993 |
| (iii) Other financial liabilities | 30 | 26 |
| Provisions | 423 | 335 |
| Deferred tax liabilities (net) | 2,086 | 1,990 |
| Other non-current liabilities | 93 | - |
| Total non-current liabilities | 19,188 | 21,607 |
| Current liabilities | | |
| Financial liabilities | | |
| (i) Borrowings # | 6,511 | 5,451 |
| (ii) Lease liabilities | 509 | 392 |
| (iii) Trade payables | - | - |
| Total outstanding dues of micro and small enterprises | 34 | 38 |
| Total outstanding dues of creditors other than micro and small enterprises | 11,984 | 10,829 |
| (iv) Rebate and refund liabilities | 5,084 | 3,781 |
| (v) Other financial liabilities | 3,663 | 2,919 |
| Other current liabilities | 5,809 | 4,390 |
| Provisions | 333 | 269 |
| Deferred tax liabilities (net) | 821 | 500 |
| Total current liabilities | 34,748 | 28,569 |
| Total liabilities | 53,936 | 50,176 |
| Total property and liabilities | 95,205 | 88,002 |

e 1000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000

| UPL
UPL Limited
AUDITED CONSOLIDATED STATEMENT OF CASH FLOWS
(₹ in Crore) | | | |
| --- | --- | --- | --- |
| Sr. No | Particulars | For the year ended | |
| | | March 31, 2026 | March 31, 2025 |
| | | (Audited) | (Audited) |
| A | Cash flow from operating activities | | |
| | Profit before tax | 3,157 | 829 |
| | Adjustments for: | | |
| | Depreciation and amortisation expenses | 3,244 | 2,750 |
| | Finance costs | 3,401 | 3,627 |
| | Impairment loss on Financial assets | 750 | 240 |
| | Assets written off | 9 | 10 |
| | Gain on sale of property, plant and equipment (net) | (9) | (61) |
| | Interest income on loans and others | (496) | (346) |
| | Unwinding of interest on trade payables and trade receivables | (474) | (340) |
| | Excess provisions in respect of earlier years written back (net) | (2) | (27) |
| | Share based payments | 70 | 39 |
| | Share of loss of associates and joint ventures (net of tax) | 194 | 472 |
| | Exceptional Items (gain)/loss (net) | (208) | 264 |
| | Profit on sale of investment (net) | (27) | (25) |
| | Fair value (gain)/loss on financial instruments at fair value through profit or loss | (10) | 5 |
| | Operating profit before working capital changes | 9,599 | 7,437 |
| | Working capital adjustments | | |
| | (Increase) / Decrease in Inventories | (2,360) | 2,460 |
| | (Increase) / Decrease in trade receivables and other assets | (4,500) | 560 |
| | Increase in trade and other payables | 5,687 | 677 |
| | Cash generated from operations | 8,426 | 11,134 |
| Income taxes paid (net) (refer note 6) | (571) | (983) | |
| | Net cash generated from operating activities | 7,855 | 10,151 |
| B | Cash flow from investing activities | | |
| | Purchase of property, plant and equipment including Capital-work-in-progress and capital advances | (1,666) | (813) |
| | Purchase of intangible assets including assets under development | (740) | (882) |
| | Proceeds from sale of property, plant and equipment | 53 | 440 |
| | Payment of deferred liabilities | (207) | (185) |
| | Investment in associates and joint ventures | (22) | (680) |
| | Purchase of non current investments | (65) | (9) |
| | Proceeds from sale of non current investments | 25 | - |
| | Purchase of current investments (net) | (313) | (48) |
| | Sundry loans (given) / received back (net) | (162) | (17) |
| | (Investments in)/Proceeds from fixed deposit and margin money, earmarked balances with bank (net) | (52) | 34 |
| | Dividend received from associates and joint ventures | 275 | 21 |
| | Interest received | 512 | 299 |
| | Net cash used in investing activities | (2,362) | (1,840) |
| C | Cash flow from financing activities | | |
| | Repayment of non-current borrowings | (4,742) | (2,137) |
| | Proceeds / (repayment) from current borrowings (net) | 575 | (3,217) |
| | Repayment of Perpetual bond | (3,409) | - |
| | Proceeds from rights issue (net of share issue expenses) (refer note 2) | 1,700 | 1,633 |
| | Interest paid and other financial charges | (2,879) | (3,328) |
| | Repayment of lease liabilities (including interest) | (641) | (530) |
| | Proceeds from equity dilution in subsidiaries (net of expenses) | - | 2,863 |
| | Dividend paid to non-controlling interest by subsidiaries | (9) | - |
| | Dividend paid | (478) | (77) |
| | Net cash used in financing activities | (9,883) | (4,793) |
| D | Effect of foreign exchange on cash and cash equivalents | 887 | 17 |
| | Net (decrease) / increase in cash and cash equivalents (A+B+C+D) | (3,503) | 3,535 |
| | Cash and cash equivalents as at the beginning of the year | 9,478 | 5,943 |
| | Cash and cash equivalents as at the end of the year | 5,975 | 9,478 |

14th Floor, United B Wing and North C Wing, Nesco IT Pub4, Nesco Center, Iers Express Highway, Corrigan (East), Mumbai - 400 063

| UPL Limited
AUDITED CONSOLIDATED SEGMENT INFORMATION
(¥ in crore) | | | | | | |
| --- | --- | --- | --- | --- | --- | --- |
| Sr.
No. | Particulars | Quarter ended | | | Year ended | |
| | | March 31, 2026 | December 31, 2025 | March 31, 2026 | March 31, 2026 | March 31, 2025 |
| | | (Unaudited)
(Refer note 9) | (Unaudited) | (Unaudited)
(Refer note 9) | (Audited) | (Audited) |
| 1 | Segment Revenue | | | | | |
| a | Crop protection | 15,422 | 9,995 | 13,123 | 42,399 | 38,865 |
| b | Seeds & Post harvest | 2,187 | 1,562 | 1,812 | 6,830 | 5,625 |
| c | Non agro | 774 | 735 | 682 | 2,803 | 2,383 |
| | Total | 18,383 | 12,292 | 15,617 | 52,032 | 46,873 |
| | Less: Inter - segment revenue | (48) | (23) | (44) | (193) | (236) |
| | Revenue from operations | 18,335 | 12,269 | 15,573 | 51,839 | 46,637 |
| 2 | Segment Results | | | | | |
| a | Crop protection | 2,423 | 1,560 | 2,393 | 5,738 | 4,900 |
| b | Seeds & Post harvest | 620 | 238 | 442 | 1,425 | 1,070 |
| c | Non agro | 29 | 87 | 63 | 344 | 236 |
| | Total | 3,072 | 1,885 | 2,898 | 7,507 | 6,206 |
| | Less : | | | | | |
| | (i) Finance costs | 836 | 774 | 914 | 3,401 | 3,627 |
| | (ii) Unallocable expenditure / (income) (net) | 251 | 303 | 305 | 816 | 870 |
| | (iii) Share of loss of associates and joint ventures net of tax | 77 | 81 | 27 | 194 | 472 |
| | (iv) Exceptional items loss/ (gain) (net)(refer note 5) | 16 | 56 | 275 | (61) | 408 |
| | a) Crop protection | 14 | 53 | 269 | (66) | 390 |
| | b) Seeds & Post harvest | 2 | 3 | 6 | 5 | 18 |
| | c) Non agro | - | - | - | - | - |
| | Profit before Tax | 1,892 | 671 | 1,377 | 3,157 | 829 |
| Sr.
No. | Particulars | As at | | | | |
| | | March 31, 2026 | December 31, 2025 | March 31, 2025 | March 31, 2026 | March 31, 2025 |
| | | (Audited) | (Unaudited) | (Audited) | (Audited) | (Audited) |
| 1 | Segment Assets | | | | | |
| | Crop protection | 70,194 | 72,699 | 63,271 | 70,194 | 63,271 |
| | Seeds & Post harvest | 8,107 | 7,146 | 6,033 | 8,107 | 6,033 |
| | Non agro | 2,162 | 1,813 | 1,327 | 2,162 | 1,327 |
| | Unallocated | 14,742 | 12,635 | 17,371 | 14,742 | 17,371 |
| | Total Assets | 95,205 | 94,293 | 88,002 | 95,205 | 88,002 |
| 2 | Segment Liabilities | | | | | |
| | Crop protection | 23,684 | 20,317 | 20,768 | 23,684 | 20,768 |
| | Seeds & Post harvest | 2,847 | 1,757 | 2,667 | 2,847 | 2,667 |
| | Non agro | 551 | 403 | 106 | 551 | 106 |
| | Unallocated | 26,854 | 33,186 | 26,635 | 26,854 | 26,635 |
| | Total Liabilities | 53,936 | 55,663 | 50,176 | 53,936 | 50,176 |

Notes :

1) The group CEO/COO/CFO/Executive directors reviewed and evaluated the Group's operating performance to make decisions about resource to be allocated and has been identified as the CODM. Utilizing the internal reporting information provided to the CODM, it has been determined that the Group has 3 business reporting segments. The business of each segment comprises of:

a) Crop protection—This is the main area of the Group's operation and includes manufacturing and marketing of conventional agrochemical products, and other agricultural related products.

b) Seeds & Post harvest — This includes manufacture and marketing of seeds & post harvesting solutions.

c) Non agro — This includes manufacturing and marketing of industrial chemical and other non agricultural related products.

2) During the year ended March 31, 2026, the Group undertook an internal reorganization to align its post-harvest solutions business (Decco) with the Seeds segment. Historically, Decco was reported under the Crop Protection segment. Following the restructuring, Decco's operations, which include coatings and post-harvest treatment products, are now managed as part of the Seeds platform, reflecting the Group's strategic integration of seed and post-harvest businesses. The Chief Operating Decision Maker (CODM) now reviews Decco's performance alongside the Seeds business for resource allocation and performance assessment. Consequently, post-harvest has been reclassified from Crop Protection to the Seeds segment for segment reporting purposes, in accordance with Ind AS 108 - Operating Segments. Comparative figures for previous year March 31, 2025, have been restated to reflect this change and ensure consistency with the current segment structure.

BSI

Nc. Nocca U. Preea Ine 1

Chartered Accountants

14th Floor, Central B Wing and North C Wing

Nesco IT Park 4, Nesco Center

Western Express Highway

Goregaon (East), Mumbai – 400 063, India

Telephone: +91 (22) 6257 1000

Fax: +91 (22) 6257 1010

Independent Auditor's Report

To the Board of Directors of UPL Limited